Ipamorelin: Selective GH Secretagogue Map

People type ipamorelin when they want the “clean” GHRP.

That is a real lane. It is not the whole GH map.

Ipamorelin is a selective growth hormone secretagogue. It binds the ghrelin receptor (GHS-R) on pituitary somatotrophs and asks for a GH pulse when the gland can still answer. It is not GHRH. It is not sermorelin with a cooler name. It is not a weekly depot of GH. It is the other key on the same gland that CJC-1295 no DAC and sermorelin knock on from the GHRH side.

This page teaches the molecule and places it on the GH map next to sermorelin, CJC-1295 / ipamorelin, tesamorelin, and the class hub on peptides for muscle growth. If a two-receptor lecture is not day one, start on Start Here.

This is education. It is not medical advice. It is not a reason to skip a clinician. It is not a “buy this to treat” pitch. A research-catalog vial is not an FDA-approved GH drug.

What is ipamorelin?

Ipamorelin is a pentapeptide GHS-R agonist. Ghrelin-receptor door. Catalogs file it under GHRP / GH secretagogue. That is accurate. GHRH it is not.

Raun, Hansen, Johansen, and colleagues described it in the European Journal of Endocrinology in 1998 as a selective growth-hormone secretagogue: GH release in the animal work without the ACTH / cortisol bump they saw with GHRP-6. You can read that paper on PubMed.

That selectivity is why the name won the catalog. GHRP-6 can move hunger and cortisol. GHRP-2 is dirtier than marketing remembers. Ipamorelin became the “clean GHRP” people actually mean when they say GHRP in a converting sentence. Still a pulse. Still short-acting. Still not a steroid. Still not HGH.

Half-life is short. You knock. The somatotroph answers if it can. Somatostatin and the rest of the axis do what they do between knocks. That is a feature if you want physiology that still looks like a pulse. It is a nuisance if you wanted a weekly pen.

Ipamorelin is not FDA-approved to treat muscle growth, aging, recovery, or “low GH vibes” in a healthy adult buying a research cake. The literature can be real. The drug label can still be missing. Those can both be true at the same time.

How ipamorelin differs from sermorelin, CJC-1295, and tesamorelin

You do not need a PhD. You need two doors, one gland, and one visceral-fat lane that is not this molecule.

Lane	What it actually is	What the evidence is	What it is not
Ipamorelin	Selective GHS-R agonist. Ghrelin-receptor door. The GHRP people usually mean.	Raun et al., European Journal of Endocrinology 1998: GH without the ACTH / cortisol bump they saw with GHRP-6. PubMed.	Not GHRH. Not sermorelin. Not a visceral-fat drug label. Not a reason to skip the stack map.
Sermorelin	GHRH 1-29. Short-acting GHRH analog. The beginner search term.	Geref-era diagnostic and pediatric GH-deficiency file. Pulse, not depot. Full map on sermorelin.	Not ipamorelin. Not CJC-1295. Not the analog many experienced users put first.
CJC-1295 no DAC	Mod GRF 1-29. Tetrasubstituted GHRH 1-29. Same door as sermorelin. Harder to degrade. Still a pulse.	Same GHRH-receptor conversation, with DPP-IV resistance. DAC is a different object. Stack page: CJC-1295 and ipamorelin.	Not “ipamorelin that lasts longer.” Not CJC with DAC. Not a steroid.
Tesamorelin	GHRH analog. Visceral-fat / abdominal-fat literature. The Egrifta-era name.	Egrifta is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. A research vial inherits neither. Map: tesamorelin.	Not a GHRP. Not a muscle-growth crown. Not “ipamorelin for belly fat.”

Same gland does not mean same job. Ipamorelin is the GHS-R key. Sermorelin and CJC-1295 no DAC are GHRH keys. Tesamorelin is still GHRH, with a labeled visceral-fat conversation behind the name. You can be interested in all four. You cannot flatten them into one Reddit protocol and call search volume a clinical result.

DAC versus no DAC still wastes money on the GHRH side. CJC-1295 with DAC binds albumin and lasts days. That is not ipamorelin. It is not “longer GHRP.” Keep the pharmacokinetic objects separate. Details live on the stack page and the muscle-growth hub.

Solo ipamorelin vs CJC + ipamorelin

Two legitimate educational questions get mashed into one shopping cart.

Solo GHRP. You are holding one door. Ghrelin / GHS-R. A selective pulse from the GHRP side. That is what this URL owns: the ipamorelin search, without pretending the second receptor is optional marketing.

CJC-1295 no DAC + ipamorelin. Two doors on the same somatotroph. GHRH analog plus GHRP. Together they can produce a larger GH pulse than either door alone. Cyril Bowers spent a career on that synergy. It is real endocrinology. It is also why catalogs sell a two-name blend and call it a personality.

Synergy is not a protocol. It is a reason the blend exists. Dose, timing, and duration stay in Pro. The public stack map lives on CJC-1295 and ipamorelin.

This page does not crown solo ipamorelin over the pulse pair. Preferring one door for yourself is not a public ranking crown. If the job is both doors, leave this URL and read the stack page. If the job is understanding the GHRP people mean when they say “clean,” stay here.

Read both names on any blend stopper. If the second name is DAC, you are not holding the pulsatile pair many people think they bought.

Research catalog vs clinic framing

Keep the bottles honest.

A research-catalog ipamorelin vial is a research-use product with a sequence name. Manufacturing claims, COAs, and what you can cite are catalog-lane problems. They are not a clinic visit. They are not an FDA label for muscle growth or aging.

Clinic / compounding / prescription GH secretagogue conversations are a different regulatory lane. Some GH-axis molecules have drug histories in other bottles (Geref for sermorelin acetate; Egrifta for tesamorelin). Ipamorelin does not inherit those labels because a forum caption said “GH peptide.”

Here is the beginner order I want on this page.

1. Name the door. GHRH or GHS-R. Ipamorelin is GHS-R.

2. Name the job. Solo GHRP education versus the two-door pulse stack versus the visceral-fat GHRH literature. Different pages. Different jobs.

3. Name the bottle. Research catalog versus labeled drug versus clinic compound. Do not launder one into the other.

4. Do not crown the search term. Ipamorelin won a lot of “clean GHRP” captions. That does not make it the answer to every GH question. The class map still lives on peptides for muscle growth.

A clinician belongs in the loop for anything that sounds like a drug. This page is not a substitute for that visit.

Reconstitution (high level)

If a lyophilized cake is even on the table, learn the math before you invent a protocol. Bacteriostatic water, U-100 syringe ticks, and not wasting ten percent of the vial live on how to reconstitute peptides.

I am not dumping a units-and-days ipamorelin protocol next to that math on a public ranking page. Dose, timing, and duration stay in Pro on purpose. Public page is the map and the reconstitution pointer.

Labs for Ipamorelin

Education first. You already got the map. This block is the labs that list ipamorelin with tracked links I will put my name on. Research-use catalog pages. Not a treatment claim. Not “buy this to treat low GH.”

Cards below are ipamorelin products only. The CJC + ipa blend conversation stays on the stack page. BioLongevity is linked at shop home when a dedicated ipamorelin product page is not listed here.

Ipamorelin — labs that list it.

BioLongevity home · LEE15

Match the product to the job. Do not collect bottles. Do not use a research catalog as a back door to a steroid cycle. Paramount’s printed code is LEE10.

Frequently asked questions about ipamorelin

Is ipamorelin the best GH peptide?

No. Ipamorelin is a selective GHS-R agonist — one door on the GH map. CJC-1295 no DAC is the GHRH pulse many people pair with it. Sermorelin is the search term beginners land on. Tesamorelin is the visceral-fat GHRH lane. Crowning one analog because a caption said “clean GHRP” is how you skip the map.

Is ipamorelin the same as CJC-1295?

No. CJC-1295 no DAC is a GHRH analog (Mod GRF 1-29). Ipamorelin is a GHS-R agonist. Different receptors. The stack exists because both doors can work together. Read CJC-1295 and ipamorelin for that pairing. This page is the ipamorelin lane.

Is ipamorelin FDA-approved?

No. Ipamorelin is not an FDA-approved treatment for muscle growth, aging, recovery, or adult GH deficiency. A research-catalog vial is not a labeled drug. Do not launder a lyophilized cake into a clinic indication.

Should I run solo ipamorelin or the CJC blend?

That is a job question, not a brand question. If you want both doors, read the stack page. If you want to understand the selective GHRP on its own, stay here. This public page does not crown solo over stack.

Can I just follow a forum ipamorelin protocol?

You can do a lot of unwise things. I would not. Name the door. Name whether DAC is in any companion bottle. Name whether you are talking about a research vial or a clinic compound. Protocol depth lives in Pro on purpose. This public page is the map, not the marching orders.

The bottom line

Ipamorelin is a selective GH secretagogue. GHS-R / ghrelin door. The GHRP people usually mean when they say “clean.”

It is not HGH. It is not GHRH. It is not the only GH answer. Sermorelin, CJC-1295 no DAC, and tesamorelin still own their lanes. The class map lives on the muscle-growth hub. The pulse pair lives on the stack page. This URL exists because people type the word and deserve the map, not a crown.

Keep the lanes. Read the papers. Do not buy a GHRP cake because a caption said selective.

Read next: CJC-1295 and ipamorelin for the pair, sermorelin for the search-term GHRH, and tesamorelin for visceral-fat literature.

I built Peptides & Pump so you can get this without a guru tax. If you want the protocol library, member discussions, and a place to think out loud before you spend money, that is Pro. If you are not ready to pay, use the free Knowledge Base first.

---

Supplier footnote: Research suppliers I mention when people ask about ipamorelin: Limitless (code LEE20), Paramount (code LEE10), Peptira (code LEE), and S1 Research (code LEE10). BioLongevity home: LEE15. Match the product to the job. Do not collect bottles.

Disclaimer. This article is for educational and research purposes only. It is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Ipamorelin is not FDA-approved for muscle growth, fat loss, aging, recovery, or for any indication discussed on this page. Sermorelin acetate (Geref) was an FDA-approved GHRH 1-29 product that was later discontinued; a research-catalog vial is not that labeled drug. CJC-1295 (with or without DAC) is not FDA-approved for muscle growth or for any indication discussed on this page. Tesamorelin (Egrifta) is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy; a research-catalog tesamorelin vial is not Egrifta. Individual results vary. Always consult a qualified healthcare provider before starting any peptide, drug, supplement, or protocol, especially if you have a medical condition or take prescription medication. Peptides & Pump does not sell peptides.

Affiliate disclosure. Some links on this page are affiliate links. If you buy through them, I may earn a commission at no extra cost to you. Codes LEE15, LEE20, LEE, LEE10 (S1), and LEE10 (Paramount) are the ones I actually use where a coupon fires. That commission is how I keep publishing free education. I only link suppliers I am willing to put my name on.